{"text": "Pentoxifylline for the treatment of infection with human immunodeficiency virus .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Cytokine dysregulation in human immunodeficiency virus type 1 ( HIV-1 ) infection has been documented in numerous studies and has been cited as an important component in the pathogenesis of this retroviral infection .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Pharmacological modification of cytokine dysregulation , therefore , has been suggested as a therapeutic modality for HIV-1 infection .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Dr . Dezube of Beth Israel Hospital ( Boston ) concisely reviews the state of our knowledge regarding the effects of pentoxifylline on expression of <extra_id_0> tumor necrosis factor-alpha <extra_id_2> Protein <extra_id_1> , a cytokine known to influence HIV-1 replication and to play a possible role in the clinical manifestations of advanced infection with this virus .", "event": "<extra_id_0> <extra_id_0> Regulation effects <extra_id_1> <extra_id_0> Theme expression <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_1> <extra_id_0> Theme tumor necrosis factor-alpha <extra_id_1> <extra_id_1>"}
{"text": "Pentoxifylline , a trisubstituted xanthine derivative , has been used to decrease blood viscosity and is reasonably well tolerated by most recipients of the drug .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Results of preliminary studies , many of which were conducted by Dr . Dezube , suggest that use of this agent in combination with antiretroviral compounds may prove useful in the treatment of patients with HIV-1 infection .", "event": "<extra_id_0> <extra_id_1>"}
